About Evolent
Evolent is a company based in Arlington (United States) founded in 2010 by Seth Blackley and Frank Williams. Evolent has raised $100 million across 1 funding round from investors including TPG, Advisory and UPMC Health Plan. The company has 4,500 employees as of December 31, 2024. Evolent offers products and services including Oncology Solution, Cardiology Solution, and Musculoskeletal Solution. Evolent operates in a competitive market with competitors including Aledade, Lumeris, Arcadia, Aetion and Advantum Health, among others.
- Headquarter Arlington, United States
- Employees 4500 as on 31 Dec, 2024
- Founders Seth Blackley, Frank Williams
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evolent Health, Inc
-
Annual Revenue
$2.55 B (USD)30.09as on Dec 31, 2024
-
Net Profit
-$61.62 M (USD)45.49as on Dec 31, 2024
-
EBITDA
$125.5 M (USD)-18.61as on Dec 31, 2024
-
Total Equity Funding
$100 M (USD)
in 1 rounds
-
Latest Funding Round
$100 M (USD), Series B
Sep 30, 2013
-
Investors
TPG
& 2 more
-
Employee Count
4500
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Evolent
Evolent is a publicly listed company on the NYSE with ticker symbol EVH in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Evolent
Evolent offers a comprehensive portfolio of products and services, including Oncology Solution, Cardiology Solution, and Musculoskeletal Solution.
Supports access to up-to-date treatment pathways for patients.
Ensures alignment with treatment and testing guidelines.
Increases high-value procedures in appropriate settings.
People of Evolent
Unlock access to complete
Unlock access to complete
Leadership Team
83 people
Product Management Team
45 people
Operations Team
37 people
Finance and Accounting
27 people
Software Development Team
24 people
Legal and Compliance
18 people
Senior Team
11 people
Board Team
7 people
Unlock access to complete
Funding Insights of Evolent
Evolent has successfully raised a total of $100M through 1 strategic funding round. The most recent funding activity was a Series B round of $100 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evolent
Evolent has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include TPG, Advisory and UPMC Health Plan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Locked | Locked | Locked | |
|
Analytics platforms and consulting services for business intelligence are offered.
|
Locked | Locked | Locked | |
|
Delivers comprehensive healthcare insurance services.
|
Locked | Locked | Locked |
Investor details for Evolent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evolent
Investment portfolio details for Evolent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evolent
Detailed financials for Evolent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evolent Comparisons
Peer comparison for Evolent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evolent
Evolent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aledade, Lumeris, Arcadia, Aetion and Advantum Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Primary care physician platform for patient care delivery is provided.
|
|
| Locked | Locked | Locked |
Lumeris offers population management and accountable care solutions
|
|
| Locked | Locked | Locked |
AI-based healthcare data analytics platform is provided for organizations.
|
|
| Locked | Locked | Locked |
Provides payer/provider, biopharma and medical device customers with a platform to allow them to gain insights into the clinical and financial status of a population
|
|
| Locked | Locked | Locked |
Healthcare providers are supported in shifting to value-based care models.
|
Detailed competitors of Evolent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evolent
Complete news archive for Evolent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evolent
Evolent was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Evolent is headquartered in Arlington, United States. It is registered at Arlington, Virginia, United States.
Seth Blackley is the current CEO of Evolent. They have also founded this company.
Evolent is a funded company, having raised a total of $100M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Evolent is 4,500.
Annual revenue of Evolent is $2.55B as on Dec 31, 2024.
Evolent was founded in 2010 and is headquartered in Arlington, United States. Operations center on the healthcare sector, where intelligent solutions are provided for managing complex conditions. Partnerships with health plans and physicians are established to support healthcare transformation. Better outcomes are targeted for individuals facing intricate health needs, with services encompassing advisory and technology integrations across the U.S.
Evolent offers Oncology Solution, Cardiology Solution, and Musculoskeletal Solution.
Yes, Evolent is publicly traded on NYSE under the ticker symbol EVH.
Evolent has 3 investors. Key investors include TPG, Advisory, and UPMC Health Plan.
The ticker symbol of Evolent is EVH on NYSE.